Latest filing published 30 Mar 2018 for PDS Biotechnology Corp.
Insider track record
No signal scores available.
Kurt G. Conti: trading record in brief
Kurt G. Conti discloses dealings in PDS Biotechnology Corp to SEC (Form 4). The record holds 7 filings, for trades running from 6 October 2015 to 23 March 2018.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 30 March 2018 came the latest disclosure, a transaction in PDS Biotechnology Corp. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Kurt G. Conti
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 58,476 shares0Common StockSEC:0001127602-18-013142:0
- 160,810 sharesCommon StockSEC:0001140361-15-037190:0
- 163,731 sharesCommon StockSEC:0001140361-15-037190:1
- 29,238 sharesCommon StockSEC:0001140361-15-037190:2
- 14,619 sharesCommon StockSEC:0001140361-15-037190:3
- 14,619 sharesCommon StockSEC:0001140361-15-037190:4
- 789,420 sharesCommon StockSEC:0001140361-15-037190:5
7 of 7 declarations
